Objective Along with aging, the elderly population with cancers is increasing. The costs of
end-of-life (EOL) care are particularly high among cancer patients. The purpose of this study …

Background No population‐based longitudinal studies on end‐of‐life (EOL) expenditures
were found for cancer decedents. Methods This population‐based, retrospective cohort …

Objectives Cancers are significant medical conditions that contribute to the rising costs of
healthcare systems and chronic diseases. This study aimed to estimate the average costs of …

Purpose: With rising health care costs in the United States, clearly defined end-of-life (EOL)
cancer costs are needed to help health administrators proactively manage this important …

Background End-of-life (EOL) care imposes heavy economic burdens on patients and health
insurers. Little is known about the association between the types of EOL care and healthcare …

Objective This study aims to quantify medical care utilisation, and to describe the cost
trajectories of individuals with advanced illnesses in the last-year of life, differentiated by …

Background: With increasing patient age in Western countries, evidence indicates a
pervasive pattern of decreasing healthcare expenditures and less aggressive medical care …

Objectives To examine the association of individual income and end of life (EOL) care in
older cancer decedents in Taiwan. Design Retrospective cohort study. Setting National …

Objective This study aimed to define the end-of-life (EOL) healthcare utilisation and its cost
and determinants for cancer patients and to proactively inform related strategies in mainland …

Introduction High-intensity end-of-life (EoL) care can be burdensome for patients,
caregivers, and health systems and does not confer any meaningful clinical benefit. Yet …